Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group
- PMID: 9022561
- DOI: 10.1093/ajcn/65.2.652S
Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group
Abstract
Phase 1 of the Trials of Hypertension Prevention was conducted in 2182 adults, aged 35-54 y, with diastolic blood pressure of 80-89 mm Hg to test the feasibility and blood pressure-lowering effects of seven nonpharmacologic interventions (weight loss, sodium reduction, stress management, and supplementation with calcium, magnesium, potassium, and fish oil). At 6 and 18 mo, weight loss and sodium reduction were well-tolerated and produced significant declines in systolic and diastolic blood pressures (-2.9/-2.4 and -2.1/-1.2 mm Hg for weight loss and sodium reduction, respectively, at 18 mo). None of the other interventions lowered blood pressure significantly at either the 6- or 18-mo follow-up visits. These results suggest that both weight loss and sodium reduction provide an effective means to prevent hypertension. The long-term effects of both of these interventions are being tested in phase 2 of the trial.
Similar articles
-
Quality of life with nonpharmacologic treatment of hypertension.Curr Hypertens Rep. 2001 Dec;3(6):466-72. doi: 10.1007/s11906-001-0008-8. Curr Hypertens Rep. 2001. PMID: 11734091 Review.
-
Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.Arch Intern Med. 1997 Mar 24;157(6):657-67. Arch Intern Med. 1997. PMID: 9080920 Clinical Trial.
-
The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.JAMA. 1992 Mar 4;267(9):1213-20. doi: 10.1001/jama.1992.03480090061028. JAMA. 1992. PMID: 1586398 Clinical Trial.
-
Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.Ann Epidemiol. 1995 Mar;5(2):156-64. doi: 10.1016/1047-2797(94)00060-7. Ann Epidemiol. 1995. PMID: 7795834 Clinical Trial.
-
Role of sodium reduction in the treatment and prevention of hypertension.Curr Opin Cardiol. 1997 Mar;12(2):202-7. doi: 10.1097/00001573-199703000-00018. Curr Opin Cardiol. 1997. PMID: 9192491 Review.
Cited by
-
Quality of life with nonpharmacologic treatment of hypertension.Curr Hypertens Rep. 2001 Dec;3(6):466-72. doi: 10.1007/s11906-001-0008-8. Curr Hypertens Rep. 2001. PMID: 11734091 Review.
-
Omega 3 fatty acids for prevention and treatment of cardiovascular disease.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003177. doi: 10.1002/14651858.CD003177.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2018 Jul 18;7:CD003177. doi: 10.1002/14651858.CD003177.pub3 PMID: 15495044 Free PMC article. Updated. Review.
-
The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial.J Hypertens. 2014 Apr;32(4):840-8. doi: 10.1097/HJH.0000000000000080. J Hypertens. 2014. PMID: 24366034 Free PMC article. Clinical Trial.
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17. J Am Coll Cardiol. 2019. PMID: 30894318 Free PMC article. No abstract available.
-
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.J Am Coll Cardiol. 2019 Nov 26;74(21):2661-2706. doi: 10.1016/j.jacc.2019.10.001. J Am Coll Cardiol. 2019. PMID: 31732293 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical